Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
| BLOOMIN' | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Molina Medicaid Solutions, an operating subsidiary of Molina Healthcare, Inc. (MOH - Analyst Report), announced that the Centers for Medicare and Medicaid Services (“CMS”) has endowed complete federation certification to implement the Medicaid Management Information System (“MMIS”) in Idaho. The system underwent stringent monitoring for a week, followed by further evaluation by CMS to successfully receive the certification.
As the federal certification will increase the monthly cost of operation, three-fourth of the MMIS operation costs incurred by Molina Medicaid Solutions will be reimbursed by the regulatory bodies. This compensation will be effective retrospectively since the system began processing the claims.
The federal government was desirous of this upgrade as the system caters to over 230,000 participants and processes approximately 140,000 claims a week.
Rising expenditures have always been a cause of concern for health care companies. The certification and reimbursement of costs will aid the company’s revenues to a certain extent.
Molina Healthcare competes closely with Unitedhealth Group, Inc. (UNH - Analyst Report). In early July, the Government Accountability Office confirmed the U.S. Department of Defense’s TRICARE Managed Care Support contract award to UnitedHealth Group.TRICARE is a health insurance service program meant for working as well as retired military service members and their families.
Under this administrative services contract, UnitedHealth will support health care delivery to approximately 2.9 million eligible beneficiaries who are active duty service members, retirees and family members based in 21 states of TRICARE’s West region. The contract consists of five one-year option periods and is valued at $20.5 billion.
Molina Healthcare is scheduled to release its second quarter results after the closing bell on July 26. The Zacks Consensus Estimate for earnings for the second quarter is currently pegged at 7 cents per share, representing an estimated year-over-year decline of 81.6%.
Molina Healthcare currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We have long-term Neutral recommendation on its shares.
Read the full Analyst Report on MOH
Read the full Analyst Report on UNH